[1]
F. Arrieta, P. Iglesias, M. Aguilar, P. Mata, and J. Pedro-Botet, “Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes”, ccm, vol. 4, no. 6, pp. 736–742, Dec. 2020.